… The primary aim of this meta-analysis was to determine the effect of aspirin in the secondary
prevention of cardiovascular disease in patients with stable cardiovascular disease. A …

… resistant before the ascertainment of any clinical outcome, or were grouped on the basis
of clinical outcome and then classified for aspirin status (we considered patients to be aspirin …

… Second, we estimated the ratio of RRs comparing the aspirin effect in patients with and … of
aspirin in patients with and without diabetes. We used Comprehensive Meta-Analysis version …

… The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial
randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and …

… The primary aim of this meta-analysis was to determine the effect of aspirin therapy in the
prevention of cardiovascular events in patients with diabetes. We searched MEDLINE, …

… without patients assigned to receive aspirin plus low-dose warfarin, we repeated the analysis
after excluding such patients. This analysis excluded SPAF 3 and the combined aspirin-low…

… effect of aspirin for asymptomatic … meta-analysis shows that the risk of first thrombotic event
is significantly decreased by low dose aspirin among asymptomatic aPL individuals, patients …

… homogenous studies are at hand, meta-analytic pooling of individual study findings …
aspirin in patients at risk for or with CAD, we thus undertook a systematic review and meta-analysis …

… risk of death in patients randomized to receive aspirin, driven … to an individual patient data
meta-analysis of primary and … In this meta-analysis, the use of aspirin in individuals without …

… estimate the mean effect of aspirin in diabetic patients. DerSimonian and Laird … meta-analysis
for the formal evaluation of this bias risk [31,32]. Subgroup analyses were done for aspirin …